Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression
IgA nephropathy (IgAN) is related to the balance of gut microbiota. However, it is unclear whether changes in the gut microbiota can cause IgAN or attenuate its progression. This study employed IgAN and human microbiota-associated (HMA)-IgAN models to investigate the impact of IgAN on gut microbiota...
Saved in:
Main Authors: | Ran Zhang, Yuyan Tang, Xiangru Feng, Xiaoxuan Lu, Mengyao Zhao, Jiayang Jin, Xiaoguo Ji, Haidong He, Liming Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2458184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Malnutrition and Its Influence on Gut sIgA–Microbiota Dynamics
by: Monica Profir, et al.
Published: (2025-01-01) -
Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
by: Wen Liu, et al.
Published: (2025-02-01) -
Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study
by: Gabriel Stefan, et al.
Published: (2024-12-01) -
Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group
by: Aysegul Oruc, et al.
Published: (2024-12-01) -
External Validation of the International Prognosis Prediction Model of IgA Nephropathy
by: Lichao Hu, et al.
Published: (2024-12-01)